Results 101 to 110 of about 3,002,254 (310)

Associations of inflammatory and hemostatic variables with the risk of recurrent stroke [PDF]

, 2005
<p><b>Background and Purpose:</b> Several prospective studies have shown significant associations between plasma fibrinogen, viscosity, C-reactive protein (CRP), fibrin D-dimer, or tissue plasminogen activator (tPA) antigen and the risk
Lowe, G.D.O., Woodward, M, A. Rumley, Neal, BC, B. C. Neal, Patel, A., M. Woodward, G. D.O. Lowe, Rumley, A., Kemp, B.E., Colman, S, Chalmers, J, Jenkins, AJ, MacMahon, Stephen, A. J. Jenkins, Jenkins, A.J., Kemp, BE, S. W. MacMahon, Woodward, M., Chalmers, J., Lowe, GD, D. J. Campbell, MacMahon, SW, Neal, B.C., Campbell, DJ, A. Patel, MacMahon, S.W., Patel, A, S. Colman, Campbell, D.J., B. E. Kemp, J. Chalmers, Rumley, A, Colman, S.   +33 more
core   +1 more source

Modern Management of Asymptomatic Carotid Stenosis: A Meta‐Analysis of CREST‐2, SPACE‐2, and ECST‐2

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Recent randomized trials (CREST‐2, SPACE‐2, and ECST‐2) have compared carotid revascularization (carotid endarterectomy [CEA] or carotid artery stenting [CAS]) plus contemporary medical therapy (CMT) versus CMT alone in asymptomatic carotid stenosis.
Aasim Ali, Waqar Ahmed Cheema, Fiza Nisar, Muhammad Shamoon, Sameen Sarfaraz, Ahmad Butt, Muhammad Abdullah Ali, Armaghana Abdullah, Muhammad Asad Shabbir, Muhammad Talha, Hammad Azam, Aimen Anwaar Pannun, Usama Saleem, Anousha Tanveer, Mukesh Sharma   +14 more
wiley   +1 more source

Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton, Carol Hermon, Sarah Floud, Gillian Reeves, Isobel Barnes   +4 more
wiley   +1 more source

Risk, Uncertainty and Life Threatening Trauma: Analysing Stroke Survivor's Accounts of Life after Stroke [PDF]

, 2006
This paper examines the ways in which stroke survivors identify and manage the risks and uncertainties of their situation. It draws on interview data from a UK study in East Kent of 31 stroke survivors (aged between 38 and 89 years).
Helen Alaszewski, Jonathan Potter, Alaszewski, Helen P., Potter, Jonathan, Andy Alaszewski, Alaszewski, Andy   +5 more
core  

Antiplatelet Therapy for Secondary Stroke Prevention: 2012 Focused Update of Korean Clinical Practice Guidelines for Stroke. [PDF]

, 2012
Writing Committee of Korean clinical practice guidelines for secondary prevention of stroke has reviewed recent randomized controlled trials of cilostazol published after the first edition of Korean clinical practice guidelines that considered evidences ...
허지회
core   +1 more source

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory

Neurology, 2022
T. Turan, O. Zaidat, G. Gronseth, M. Chimowitz, A. Culebras, A. Furlan, L. Goldstein, Nestor R. Gonzalez, J. Latorre, S. Messé, Thanh N. Nguyen, Rajbeer S. Sangha, M. Schneck, A. Singhal, L. Wechsler, A. Rabinstein, Mary Dolan O'Brien, Heather M. Silsbee, J. Fletcher   +18 more
semanticscholar   +1 more source

Augmenting and Assaying Nav1.1 Protein Quantity for Dravet Syndrome Therapy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Dravet Syndrome (DS) is a developmental and epileptic encephalopathy predominantly caused by heterozygous loss‐of‐function variants in SCN1A, which encodes Nav1.1. Conserved upstream open reading frames (uORFs) in SCN1A were validated to regulate translation in reporter assays, demonstrating the therapeutic viability of increasing Nav1.1 from ...
Aiswarya Saravanan, Jordan Safran, Anna Loughman, Grace Lin, Shivanshi Vaid, Dana Allababidi, Peter M. Tessier, Louis T. Dang   +7 more
wiley   +1 more source

Evaluating a Pragmatic Strength Alternative for Frailty Measurement and Assessing Its Predictive Capacity Against Established Frailty Instruments in Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Frailty occurs prematurely in rheumatoid arthritis (RA) and is associated with poor health outcomes. We compared the performance of four frailty instruments, including a pragmatic alternative measure using chair sit‐to‐stand (STS), and evaluated their abilities to predict poor health outcomes.
Kylie E. Riggles, Hannah F. Brubeck, Adrienne D. Tanus, Courtney N. Loecker, Punyasha Roul, Bryant R. England, Elizabeth R. Wahl, James S. Andrews, Namrata Singh, Joshua F. Baker, Patricia P. Katz, Dolores M. Shoback, Jose M. Garcia, Ariela R. Orkaby, Katherine D. Wysham   +14 more
wiley   +1 more source

Putting Your Health in Your Own Hands: A New Strategy for Primary Stroke Prevention [PDF]

, 2015
As evidenced by the increasing stroke burden worldwide, currently used primary stroke prevention strategies are not effective enough. One of the main reasons for insufficient effectiveness of the currently used primary stroke prevention strategies are ...
Krishnamurthi, R, Bhattacharjee, R, Feigin, VL   +2 more
core  

Endovascular Therapy in the Extended Time Window for Large Vessel Occlusion in Patients With Pre-Stroke Disability [PDF]

Endovascular therapy; Ischemic stroke; ReperfusionTerapia endovascular; Ictus isquémico; ReperfusiónTeràpia endovascular; Ictus isquèmic; ReperfusióBackground and Purpose We compared the outcomes of endovascular therapy (EVT) in an extended time window ...
Uchida, Kazutaka, Yamagami, Hiroshi, Siegler, James, Nogueira, Raul, Tanaka, Kanta, Requena, Manuel, Ribo, Marc, Olive-Gadea, Marta, Qureshi, Muhammad M.   +8 more
core   +1 more source